A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes

Phase 3 Completed 49 enrolled Eli Lilly and Company

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the compatibility and safety of LY900014 and insulin lispro with an external continuous subcutaneous insulin infusion system in adult participants with type 1 diabetes.

Timeline

Start: 2018-02-21
Primary completion: 2018-09-04
Completion: 2018-09-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Insulin Lispro	Protein / enzyme biologic	100 unknown	Subcutaneous

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes

Summary

Timeline

Drugs

Indications